Monozyme India Ltd (522199) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 522199 | NSE: | Hospital & Healthcare Services | Small Cap

BSE Share Price
Not Listed

Monozyme India Ltd (522199) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 522199 | NSE: | Hospital & Healthcare Services | Small Cap

DeciZen - make an informed investing decision on Monozyme India

Based on:

M-Cap below 100cr DeciZen not available

Monozyme India stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
2.8 Cr.
52-wk low:
0
52-wk high:
0

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Monozyme India:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'99Mar'00Mar'01Mar'02Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08TTM
ROCE % 13.2%11.8%12.9%11.3%13.5%19.2%11.4%13.3%-9.8%3.8%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 3.94.44.85.89.812.69.410.65.100
Sales YoY Gr.-12.9%9.1%20.7%69%28.7%-25%12%-52%-99.4%-
Adj EPS 0.10.10.20.20.30.60.20.5-2-0.8-0.3
YoY Gr.-12.5%88.9%11.8%31.6%132%-65.5%155%-498%NA-
BVPS (₹) 3.233.13.23.33.94.14.62.52.32.3
Adj Net
Profit
0.10.10.10.10.20.40.10.3-1.3-0.5-0
Cash Flow from Ops. 0.2-0.40.20.3-0-0.4-0.2-1.4-0.21.2-
Debt/CF from Ops. 11.3-5.19.67.1-58.1-7-17.1-4-22.42.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -41.8%-68.6%-85.3%-99.4%
Adj EPS -228.8%-225.6%-257.4%NA
BVPS-3.8%-7%-18%-11%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'99Mar'00Mar'01Mar'02Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08TTM
Return on
Equity %
1.41.52.93.2411.55.111.9-58-33.3-11.8
Op. Profit
Mgn %
1410.811.98.45.97.46.78.7-12.8-4203.4-241.3
Net Profit
Mgn %
1.41.32.32.11.62.91.33.1-25.6-1447-574.2
Debt to
Equity
0.91.110.911.111.93.11.9-
Working Cap
Days
40037531924919119826925452255,5660
Cash Conv.
Cycle
1731858753496411035452,2860

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Monozyme India Ltd.

Standalone Consolidated
TTM EPS (₹) -0.3 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 2.3 -
Reserves (₹ Cr.) -2 -
P/BV 1.90 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) 0.05 / 47.50
Market Cap (₹ Cr.) 2.8
Equity (₹ Cr.) 3.2
Face Value (₹) 5
Industry PE 89.9

Management X-Ray of Monozyme India:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Monozyme India - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Monozyme India

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'99Mar'00Mar'01Mar'02Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08
Sales3.894.394.795.789.7712.579.4310.565.070.03
Operating Expenses 3.363.924.265.299.2011.648.809.645.731.49
Manufacturing Costs0.290.510.410.480.570.700.600.740.300.15
Material Costs1.591.592.042.475.297.424.795.523.151.06
Employee Cost 0.380.470.580.620.831.261.451.491.410.07
Other Costs 1.101.351.231.732.512.261.961.890.870.21
Operating Profit 0.540.470.540.480.580.930.630.92-0.66-1.45
Operating Profit Margin (%) 13.8%10.8%11.2%8.4%5.9%7.4%6.7%8.7%-13.0%-4,213.8%
Other Income 0.020.040.020.010.030.020.030.050.061.75
Interest 0.450.390.410.310.340.380.330.380.490.37
Depreciation 0.050.060.060.060.060.070.070.080.130.10
Exceptional Items 0000000000
Profit Before Tax 0.050.070.100.130.200.500.250.51-1.22-0.17
Tax 0.010.010.0100.050.130.130.180.090
Profit After Tax 0.050.060.090.120.160.370.130.33-1.30-0.17
PAT Margin (%) 1.2%1.3%1.8%2.1%1.6%2.9%1.3%3.1%-25.7%-506.0%
Adjusted EPS (₹)0.10.10.10.20.30.60.20.5-2.1-0.3
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'99Mar'00Mar'01Mar'02Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08

Equity and Liabilities

Shareholders Fund 3.753.803.883.854.012.422.552.891.581.41
Share Capital 3.113.113.113.113.113.113.113.123.123.12
Reserves 0.640.680.770.740.90-0.69-0.56-0.23-1.54-1.71
Minority Interest0000000000
Debt1.742.081.911.882.112.662.585.384.932.72
Long Term Debt1.742.081.911.882.112.662.585.384.932.72
Short Term Debt0000000000
Trade Payables2.161.851.361.403.513.922.722.590.490
Others Liabilities 0.060.050.030.180.230.340.310.3810.72
Total Liabilities 7.707.787.197.319.859.348.1611.2484.85

Fixed Assets

Gross Block1.061.071.081.111.331.291.331.461.471.30
Accumulated Depreciation0.310.360.410.470.530.600.670.750.880.90
Net Fixed Assets 0.760.700.670.640.800.690.670.710.590.40
CWIP 0000.360.360.410.411.341.340
Investments 0000000000
Inventories1.021.181.101.312.262.401.842.341.300
Trade Receivables2.442.612.462.563.655.144.325.494.494.12
Cash Equivalents 0.160.130.120.330.330.550.300.730.010.03
Others Assets 3.323.162.832.102.450.160.630.630.270.31
Total Assets 7.707.787.197.319.859.348.1611.2484.85

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'99Mar'00Mar'01Mar'02Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08
Cash Flow From Operating Activity 0.15-0.410.200.26-0.04-0.38-0.15-1.35-0.221.17
PBT 0.050.070.100.130.200.500.250.51-1.22-0.17
Adjustment 0.400.190.400.430.252.420.380.390.560.47
Changes in Working Capital 0.15-0.30.07-0.01-0.14-0.94-0.26-1.690.891.24
Tax Paid -0.01-0.01-0.01-0.01-0.01-0.03-0.19-0.1800
Cash Flow From Investing Activity -0.050.02-0.04-0.02-0.200.06-0.02-1.030.051.90
Capex -0.06-0-0.06-0.03-0.220.04-0.05-1.06-0.011.90
Net Investments 0000000000
Others 0.010.030.020.010.020.020.030.030.060
Cash Flow From Financing Activity -0.070.35-0.17-0.040.230.55-0.082.80-0.45-2.21
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing -0.040.01-0.200.04-0.060.57-0.503.2600
Interest Paid 0000000000
Dividend Paid 0000000000
Others -0.030.330.04-0.080.29-0.020.42-0.46-0.45-2.21
Net Cash Flow 0.03-0.04-0.010.21-00.23-0.250.43-0.620.86

Finance Ratio

PARTICULARSMar'99Mar'00Mar'01Mar'02Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08
Ratios
ROE (%)2.312.984.646.257.8816.585.0712.21-58.4-11.67
ROCE (%)13.1711.8212.9411.3313.5419.1911.4113.28-9.843.76
Asset Turnover Ratio0.540.590.670.831.171.351.121.130.530.01
PAT to CFO Conversion(x)3-6.832.222.17-0.25-1.03-1.15-4.09N/AN/A
Working Capital Days
Receivable Days2052031861531131241761633590
Inventory Days94898473656579691310
Payable Days41746028720416918325317617884

Monozyme India Ltd Stock News

Monozyme India Ltd FAQs

The current trading price of Monozyme India on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Monozyme India stood at ₹2.82.
The latest P/E ratio of Monozyme India as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Monozyme India as of 31-Dec-1969 is 1.90.
The 52-week high of Monozyme India is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Monozyme India is ₹0.03 ( Cr.) .

About Monozyme India Ltd

Monozyme India was incorporated on July 7, 1989, as a private company for the purpose of manufacturing diagnostic kits. Subsequently, the company was converted into a public company vide special resolution passed in the annual general meeting of the company held on September 30, 1991. The company obtained fresh certificate of incorporation consequent on change of name from the Registrar of Companies, Andhra Pradesh on October 31, 1991. Monozyme India is promoted by A R Vishwanath & Associates. The company commenced commercial operations on May 15, 1991.

The manufacturing plant of the company is located at Secunderabad in Andhra Pradesh. Constant in-house research and development is undertaken and new technology developed thereon is absorbed.

The registered office is at Flat 402, S.S. Residency, Plot No. 3, Center Point, Brig Syed Road, Secunderabad-500009, Andhra Pradesh.

Business area of the company

Monozyme India is engaged in the business of diagnostic and clinical chemistry kits and enzymes.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×